Maintenance Treatment Delays Progression in Metastatic Colorectal Cancer
Maintenance Treatment Delays Progression in Metastatic Colorectal Cancer By Caroline Helwick August 15, 2013, Volume 4, Issue 13 FROM ASCO POST Expert Point of View: Tim Maughan, MD Figures: For patients with unresectable metastatic colorectal cancer, maintenance treatment with capecitabine (Xeloda) and bevacizumab (Avastin) significantly delayed disease progression and improved overall survival in the phase […]
More